Edwards Lifesciences Corp (EW)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$1.51 (+2.19%)Past Day

About

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Key Insights

  • Share Price

    $70.30

  • Market Cap

    $42.35 Billion

  • Total Outstanding Shares

    602.40 Million Shares

  • Total Employees

    19,800

  • Dividend

    No dividend

  • IPO Date

    April 3, 2000

  • SIC Description

    Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Homepage

    https://www.edwards.com

Historical Stock Splits

If you bought 1 share of EW before May 28, 2010, you'd have 12 shares today.
Execution DateSplit Amount
June 1, 20203-for-1
December 14, 20152-for-1
May 28, 20102-for-1

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$866.10 Million
Net Cash Flow From Investing Activities, Continuing$291.00 Million
Net Cash Flow From Financing Activities, Continuing$-591.40 Million
Net Cash Flow$610.60 Million
Net Cash Flow From Operating Activities$866.10 Million
Net Cash Flow From Financing Activities$-591.40 Million
Net Cash Flow, Continuing$565.70 Million
Net Cash Flow From Investing Activities$291.00 Million
Exchange Gains/Losses$44.90 Million

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Income/Loss$1.47 Billion
Basic Earnings Per Share$2.43
Net Income/Loss Available To Common Stockholders, Basic$1.47 Billion
Basic Average Shares$1.21 Billion
Gross Profit$4.62 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income/Loss From Continuing Operations Before Tax$1.62 Billion
Operating Expenses$2.92 Billion
Net Income/Loss Attributable To Parent$1.47 Billion
Net Income/Loss Attributable To Noncontrolling Interest$-3.60 Million
Diluted Average Shares$1.21 Billion
Selling, General, and Administrative Expenses$1.80 Billion
Revenues$6.00 Billion
Operating Income/Loss$1.54 Billion
Income/Loss From Continuing Operations After Tax$1.45 Billion
Income Tax Expense/Benefit$174.40 Million
Diluted Earnings Per Share$2.43
Other Operating Expenses$87.60 Million
Benefits Costs and Expenses$4.34 Billion
Costs And Expenses$4.34 Billion
Research and Development$1.07 Billion
Cost Of Revenue$1.38 Billion
Preferred Stock Dividends And Other Adjustments$0.00

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Fixed Assets$1.64 Billion
Current Liabilities$1.22 Billion
Current Assets$4.52 Billion
Assets$10.10 Billion
Liabilities And Equity$10.10 Billion
Intangible Assets$417.10 Million
Other Non-current Assets$3.53 Billion
Wages$288.70 Million
Equity Attributable To Parent$7.44 Billion
Noncurrent Liabilities$1.38 Billion
Equity$7.50 Billion
Equity Attributable To Noncontrolling Interest$67.20 Million
Prepaid Expenses$110.20 Million
Accounts Payable$185.90 Million
Noncurrent Assets$5.58 Billion
Other Current Liabilities$742.40 Million
Other Current Assets$3.38 Billion
Inventory$1.02 Billion
Liabilities$2.59 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
News ArticlesAbout UsPrivacy Policy & Cookies Information

ⓒ2024 Financhle. All Rights Reserved.